AviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations November 6, 2023
ABK Biomedical Announces First Patient Treated in its Multi-Center Pivotal Study of Eye90 microspheres® in Hepatocellular Carcinoma October 24, 2023
NodThera announces first patients dosed in a Phase Ib/IIa cardiovascular risk trial of NLRP3 inflammasome inhibitor NT-0796 October 16, 2023
AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in People with Frontotemporal Dementia with GRN Mutations October 10, 2023
Rippl and McLean Hospital collaborate to build ‘first of its kind’ dementia training program October 9, 2023
Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials October 6, 2023